hexamethonium has been researched along with Cardiac Death in 2 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| KLAYMAN, MI | 1 |
| SILBERG, NR | 1 |
| KARLEN, WS | 1 |
| GOLDSMITH, HJ | 1 |
2 other studies available for hexamethonium and Cardiac Death
| Article | Year |
|---|---|
Death associated with hexamethonium and 1-hydrazinophthalazine (apresoline) therapy.
Topics: Cardiovascular Agents; Death; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; S | 1953 |
Death from hexamethonium ileus.
Topics: Death; Hexamethonium; Humans; Ileus; Intestinal Obstruction; Muscle Relaxants, Central | 1955 |